• Methyl-β-cyclodextrin: Technical Parameters for Membrane Res

  2026-07-15

  Methyl-β-cyclodextrin addresses the challenge of selective cholesterol and lipid extraction from cellular membranes, enabling precise modulation of membrane fluidity and organization in research settings. This reagent is optimized for laboratory-based studies of lipid rafts and cholesterol-dependent pathways, but is not suitable for diagnostic or medical applications.

• Br-DAPI (SKU BA3947): Reliable DNA Quantification for Cell A

  2026-07-15

  This article addresses practical challenges in cell viability and DNA quantification workflows by examining how Br-DAPI (SKU BA3947) enhances sensitivity, selectivity, and reproducibility. Drawing from real laboratory scenarios, it provides protocol guidance and vendor-selection insights for biomedical researchers seeking robust results with advanced DAPI fluorescent dye technology.

• Demethyleneberberine as a Multi-Target Candidate in Huntingt

  2026-07-14

  The referenced study hypothesizes that Demethyleneberberine (DMB), a metabolite of berberine, offers neuroprotective effects in Huntington’s disease (HD) by mitigating oxidative stress, mitochondrial dysfunction, and neuroinflammation. This mechanistic perspective highlights DMB’s potential to address multiple pathological pathways relevant to neurodegeneration, supporting its further investigation as a multi-target agent in HD and related models.

• Trelagliptin Succinate Restores Chondrocyte Function via AMP

  2026-07-14

  This study demonstrates that trelagliptin succinate (SYR-472 succinate), a DPP-4 inhibitor, protects human chondrocytes from IL-1β-induced dysfunction by activating the AMPK/SOX-9 pathway. The findings reveal a novel anti-inflammatory mechanism for trelagliptin, suggesting broader applications beyond glycemic control, particularly in osteoarthritis and diabetes-related cartilage degeneration.

• Anti-ROR1 Antibody (Zilovertamab): Enabling Mechanistic Prec

  2026-07-13

  Explore how Anti-ROR1 Antibody (Zilovertamab) empowers mechanistic studies at the intersection of cancer and liver injury, with unique insights into assay design, specificity, and cross-domain modeling. This article reveals practical value for advanced oncology and hepatotoxicity research.

• Leucomycin (Kitasamycin): Advanced Workflows for Translation

  2026-07-13

  Leucomycin (kitasamycin) stands out as a robust tool for translational inhibition studies and resistance profiling in bacterial research. This article delivers optimized workflows, troubleshooting strategies, and actionable insights—bridging bench protocols with real-world antibacterial drug discovery using APExBIO's high-purity compound.

• V5 Epitope Tag Peptide: Precision Protein Tagging and Detect

  2026-07-12

  The V5 Epitope Tag Peptide streamlines protein tracking and multiplex detection, leveraging recent advances in fast-dissociating antibody screening for dynamic imaging and high-throughput workflows. Discover experimental enhancements, troubleshooting strategies, and protocol parameters that maximize reliability and sensitivity in recombinant protein studies.

• DMXAA (Vadimezan): Mechanistic Depth and Next-Gen Assay Desi

  2026-07-10

  Explore DMXAA (Vadimezan) as an advanced apoptosis inducer in tumor endothelial cells, with a distinct focus on mechanistic insights, protocol strategies, and the latest STING-JAK1 research. Uncover actionable guidance for cancer biology research beyond standard overviews.

• CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor Insig

  2026-07-09

  CHIR 99021 trihydrochloride is a potent, selective GSK-3 inhibitor used to modulate self-renewal and differentiation in organoid and stem cell models. Its high specificity enables reproducible control of cellular fate, supporting advanced research in metabolism, diabetes, and regenerative biology. This review details mechanism, benchmarks, and protocol parameters with verifiable citations.

• Targeting Methylation in HSC Activation: 3-Deazaadenosine HC

  2026-07-09

  This thought-leadership article explores the mechanistic role of 3-Deazaadenosine hydrochloride as a S-adenosylhomocysteine hydrolase inhibitor in hepatic stellate cell activation, with strategic recommendations for translational fibrosis research. Integrating new evidence on the m6A–IGF2BP1–TUBB4B axis, it offers protocol guidance, competitive analysis, and a forward-looking perspective on APExBIO’s high-purity reagent.

• Deferasirox Fe3+ Chelate: Precision Iron Chelation Workflows

  2026-07-08

  Deferasirox Fe3+ chelate empowers iron overload research with exceptional DMSO solubility, high assay reproducibility, and advanced mechanistic precision. This guide delivers actionable workflows, troubleshooting advice, and comparative insights to optimize beta-thalassemia and chronic anemia studies.

• Workflow Guidance for HyperPFU™ High-Fidelity DNA Polymerase

  2026-07-08

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate PCR amplification of long, complex, or GC-rich DNA templates, where standard enzymes often fail due to low fidelity or processivity. It is not suitable for protocols requiring 3'-A overhangs or sticky ends, and should be used in workflows needing blunt-ended, high-fidelity products.

• Inhibition of uPAR-uPA Interaction: IPR-803 in Breast Cancer

  2026-07-07

  This study demonstrates that IPR-803, a small-molecule urokinase receptor inhibitor, directly disrupts the uPAR-uPA interaction, effectively reducing breast cancer cell invasion and metastasis in vitro and in vivo. The paper offers mechanistic and pharmacokinetic evidence supporting IPR-803 as a foundational compound for translational anti-metastatic research.

• ApexPrep DNA Plasmid Miniprep Kit: Precision Plasmid Purific

  2026-07-07

  Unlock high-yield, molecular biology grade plasmid DNA extraction with the ApexPrep DNA Plasmid Miniprep Kit. Streamline AML gene regulation studies and next-gen cloning with reproducible purity, rapid protocols, and robust troubleshooting guidance.

• SR-202: Advancing PPARγ Antagonism in Immune-Metabolic Resea

  2026-07-06

  Explore how SR-202, a selective PPARγ antagonist, enables translational researchers to dissect immune-metabolic pathways, bridge the gap between mechanistic insight and therapeutic innovation, and redefine experimental strategies in obesity, type 2 diabetes, and inflammatory disease research.

446 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page